Navidea Biopharmaceuticals Announces SNMMI Press Release and Recognition of Phase 1/2 Study Results

 

Navidea Biopharmaceuticals Announces SNMMI Press Release and Recognition of Phase 1/2 Study Results

SEE ALSO: IPO experts explain why it’s dangerous to hop onto red-hot stocks like Beyond Meat — and share their best advice for regular investors » READ NOW: 2 Royal Air Force fighter jets …

More Navidea Biopharmaceuticals Announces SNMMI Press Release and Recognition of Phase 1/2 Study Results Videos

Leave a Reply